Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
Nidhi Tandon, Vijay Ramakrishnan, Shaji K Kumar Division of Hematology, Mayo Clinic, Rochester, MN, USA Abstract: The incorporation of various novel therapies has resulted in a significant survival benefit in newly diagnosed and relapsed patients with multiple myeloma (MM) over the past decade. Desp...
Saved in:
Main Authors: | Tandon N (Author), Ramakrishnan V (Author), Kumar SK (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020) -
Clinical Toxicities of Histone Deacetylase Inhibitors
by: Richard L. Piekarz, et al.
Published: (2010) -
Application of Histone Deacetylase Inhibitors in Renal Interstitial Fibrosis
by: Ling Nie, et al.
Published: (2020) -
Medicinal chemistry of histone deacetylase inhibitors
by: Ružić Dušan, et al.
Published: (2021) -
Zinc binding groups for histone deacetylase inhibitors
by: Lei Zhang, et al.
Published: (2018)